Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France

Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France

IntroductionHeart transplant (HT) recipients have a high risk of developing severe COVID-19. Immunoglobulin G antibodies are considered to provide protective immunity and T-cell activity is thought to confer protection from severe disease. However, data on T-cell response to mRNA vaccination in a co...

Full description

Bibliographic Details
Main Authors: Alice Casenaz, Sandrine Grosjean, Ludwig-Serge Aho-Glélé, Jean-Baptiste Bour, Christelle Auvray, Catherine Manoha
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
heart transplant recipient
mRNA vaccine
BNT162b2
T cell
smoking
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1027708/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1027708/full

Similar Items